Donald J. Griffith - Net Worth and Insider Trading
Donald J. Griffith Net Worth
The estimated net worth of Donald J. Griffith is at least $5,681 dollars as of 2024-11-13. Donald J. Griffith is the Director of Outlook Therapeutics Inc and owns about 906 shares of Outlook Therapeutics Inc (OTLK) stock worth over $5,681. Details can be seen in Donald J. Griffith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Donald J. Griffith has not made any transactions after 2016-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Donald J. Griffith
Donald J. Griffith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Donald J. Griffith owns 2 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) , and Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Donald J. Griffith’s form 4 insider trades.
Insider Ownership Summary of Donald J. Griffith
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SONN | Sonnet BioTherapeutics Holdings Inc | 2020-04-01 | director |
OTLK | Outlook Therapeutics Inc | 2016-11-23 | director |
Donald J. Griffith Latest Holdings Summary
Donald J. Griffith currently owns a total of 1 stock. Donald J. Griffith owns 906 shares of Outlook Therapeutics Inc (OTLK) as of November 23, 2016, with a value of $5,681.
Latest Holdings of Donald J. Griffith
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
OTLK | Outlook Therapeutics Inc | 2016-11-23 | 906 | 6.27 | 5,681 |
Holding Weightings of Donald J. Griffith
Donald J. Griffith Form 4 Trading Tracker
According to the SEC Form 4 filings, Donald J. Griffith has made a total of 0 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years. The most-recent trade in Outlook Therapeutics Inc is the sale of 0 shares on November 23, 2016, which brought Donald J. Griffith around $4.
Insider Trading History of Donald J. Griffith
- 1
Donald J. Griffith Trading Performance
Donald J. Griffith Ownership Network
Ownership Network List of Donald J. Griffith
Ownership Network Relation of Donald J. Griffith
Donald J. Griffith Owned Company Details
What does Sonnet BioTherapeutics Holdings Inc do?
Who are the key executives at Sonnet BioTherapeutics Holdings Inc?
Donald J. Griffith is the director of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , Chief Technical Officer Susan Dexter , and director & Chairman & President and CEO Pankaj Mohan .
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary
Over the past 18 months, Donald J. Griffith made no insider transaction in Sonnet BioTherapeutics Holdings Inc (SONN). Other recent insider transactions involving Sonnet BioTherapeutics Holdings Inc (SONN) include a net purchase of 371,600 shares made by Pankaj Mohan , a net purchase of 25,000 shares made by Nailesh Bhatt , and a net purchase of 23,255 shares made by Albert D. Dyrness .
In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 2,442 shares were bought by its insiders, resulting in a net purchase of 2,442 shares.
Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonnet BioTherapeutics Holdings Inc Insider Transactions
Donald J. Griffith Mailing Address
Above is the net worth, insider trading, and ownership report for Donald J. Griffith. You might contact Donald J. Griffith via mailing address: C/o Sonnet Biotherapeutics Holdings, Inc, 100 Overlook Center, Princeton Nj 08540.